EVac 70 XTRA with Integrated Cable and PROcise EZ View with Integrated Cable Product Usage: P...

FDA Device Recall #Z-2105-2015 — Class II — June 2, 2015

Recall Summary

Recall Number Z-2105-2015
Classification Class II — Moderate risk
Date Initiated June 2, 2015
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm ArthroCare Corporation
Location Austin, TX
Product Type Devices
Quantity 733 devices

Product Description

EVac 70 XTRA with Integrated Cable and PROcise EZ View with Integrated Cable Product Usage: PLASMA WAND devices are indicated for ablation, resection, and coagulation of soft tissue and hemostasis of blood vessels in otorhinolaryngology (ENT) surgery including: adenoidectomy, cysts, head, neck, oral, and sinus surgery, mastoidectomy, myringotomy with effective hemorrhage control, nasal airway obstruction be reduction of hypertrophic nasal turbinates, nasopharyngeal/laryngeal indications including tracheal procedures, laryngeal polypectomy, and laryngeal lesion debulking, neck mass, papilloma keloids, submucosal palatal shrinkage, submucosal tissue shrinkage, tonsillectomy (including palatine tonsils), traditional uvulopalatoplasty (RAUP), tumors, and tissue in the uvula/soft palate for the treatment of snoring. It is intended for procedures using a conductive media, such as normal saline or Ringers lactate.

Reason for Recall

Wands inspected with the adaptor fixture were released to the field not meeting the dielectric (Hipot) specifications.

Distribution Pattern

Worldwide Distribution - US Nationwide and the countries of Australia, Belgium, Germany, Spain, United Kingdom, Ireland, India, Italy and Singapore.

Lot / Code Information

Lot numbers 1093290 and 1091254

Other Recalls from ArthroCare Corporation

Recall # Classification Product Date
Z-2999-2020 Class II Speed Stitch Needle Cassette Aug 17, 2020
Z-3000-2020 Class II Smith&Nephew SmartStitch PerfectPasser Connecto... Feb 21, 2019
Z-1321-2016 Class II TOPAZ MicroDebrider 0.8 mm REF AC4040-01; TOPAZ... Mar 3, 2016
Z-0623-2016 Class II Cavity 8 Gauge Spine Wand indicated for resecti... Oct 26, 2015

Frequently Asked Questions

Contact your physician immediately if you use an electrical device or implant affected by this recall. For external devices (monitors, pumps), stop using the device and contact the manufacturer for a replacement. For implanted devices (pacemakers, ICDs), your cardiologist will assess whether you need device replacement surgery — the decision depends on how dependent you are on the device and the actual failure rate observed in the field. Do not attempt to repair or modify a recalled electrical medical device yourself. Monitor for any new or unusual symptoms and report them to your doctor.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.